Editorial Comment to Sodium glucose-linked transport protein 2 inhibitors: An overview of genitourinary and perioperative implications

被引：0
|
作者：
Hiyama, Yoshiki [1 ]
机构：
[1] Hakodate Goryoukaku Hosp, Dept Urol, Hakodate, Hokkaido, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2021年 / 28卷 / 10期
关键词：
D O I：
10.1111/iju.14639
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：990 / 991
页数：2
相关论文
共 50 条
  • [41] Management of sodium-glucose cotransporter 2 inhibitors during the perioperative period: A retrospective comparative study
    Ge, Victor
    Subramaniam, Ashwin
    Banakh, Iouri
    Wang, Wei Chun
    Tiruvoipati, Ravindranath
    JOURNAL OF PERIOPERATIVE PRACTICE, 2021, 31 (10) : 391 - 398
  • [42] Prevalence of Genitourinary Infections with Sodium Glucose Co-transporter-2 (sglt2) inhibitors in patients with type 2 diabetes
    Hussain, Mazhar
    Hussain, Abid
    Rehman, Habib Ur
    Iqbal, Javed
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (10): : 2804 - 2807
  • [43] The association of sodium-glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews
    Pelletier, Ryan
    Ng, Kelvin
    Alkabbani, Wajd
    Labib, Youssef
    Mourad, Nicolas
    Gamble, John-Michael
    ENDOCRINOLOGY DIABETES & METABOLISM, 2020, 3 (03)
  • [44] Sodium-glucose co-transporter-2 inhibitors and the risk of perioperative euglycaemic diabetic ketoacidosis
    Williams, Samuel P.
    Stevens, Jia L.
    Rajendran, Yohinee K.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2022, 83 (11)
  • [45] Perioperative cessation of sodium-glucose cotransporter-2 inhibitors: 72 hours or seven days?
    Tan, H. L. E.
    Acharya, S.
    ANAESTHESIA AND INTENSIVE CARE, 2018, 46 (04) : 425 - 427
  • [46] The Off-Target Cardioprotective Mechanisms of Sodium-Glucose Cotransporter 2 Inhibitors: An Overview
    Ionica, Loredana N.
    Linta, Adina V.
    Batrin, Alina D.
    Hancu, Iasmina M.
    Lolescu, Bogdan M.
    Danila, Maria D.
    Petrescu, Lucian
    Mozos, Ioana M.
    Sturza, Adrian
    Muntean, Danina M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [47] Sodium-glucose linked transporter 2 inhibitors in liver cirrhosis: Beyond their antidiabetic use
    Siafarikas, Christos
    Kapelios, Chris J.
    Papatheodoridi, Margarita
    Vlachogiannakos, John
    Tentolouris, Nikolaos
    Papatheodoridis, George
    LIVER INTERNATIONAL, 2024, 44 (04) : 884 - 893
  • [48] Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors
    Rizzi, M.
    Trevisan, R.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2016, 26 (11) : 963 - 970
  • [49] Editorial: The role of sodium-glucose cotransporter 2 inhibitors in the management of chronic kidney disease
    Heerspink, Hiddo J. L.
    Fouque, Denis
    Wanner, Christoph
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1 - 2
  • [50] Short term sodium glucose transport protein 2 inhibitors are associated with post contrast acute kidney injury in patients with diabetes
    Zang, Jiabin
    Liang, Jianwen
    Zhang, Xiaocong
    Sang, Dan
    Duan, Xinyue
    Wang, Zhenyu
    Wei, Wenbin
    Wu, Guifu
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345